Skip to main content

Published locations for EASD: Monthly incretin-based therapy shows promise in type 2 diabetes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EASD: Monthly incretin-based therapy shows promise in type 2 diabetes

User login

  • Reset your password
  • /content/easd-monthly-incretin-based-therapy-shows-promise-type-2-diabetes
  • /familypracticenews/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type-2
  • /internalmedicinenews/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type
  • /clinicalendocrinologynews/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise
  • /diabeteshub/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type-2
  • /endocrinology/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type-2
  • /internalmedicine/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type-2
  • /familymedicine/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type-2
  • /type-2-diabetes-icymi/article/103236/diabetes/easd-monthly-incretin-based-therapy-shows-promise-type